IDGLOBAL Corporation
(OTC: IDGJ)
IDGLOBAL Announces 10-Year Contract with Major Pharmaceutical Label Manufacturer
KELOWNA, British Columbia–IDGLOBAL (OTC: IDGJ) is pleased to announce to its shareholders that IDGLOBAL has secured an unprecedented ten (10)-year contract to supply its Nano-Molecular Marking(TM), anti-counterfeiting technology, to the renowned pharmaceutical labeling corporation ATL Pharma Security Label Systems(TM) (www.atlco.com), a division of Ad Tape & Label Co. This 10-year supply contract guarantees ATL the ability to incorporate IDGlobal’s Nano-Molecular Marking(TM) technologies into any of ATL’s Pharmaceutical labeling solutions to provide its clients the highest level of protection against counterfeited labels.
ATL is one of the world’s leading secure label solutions providers, manufacturing more than half of all pharmaceutical clinical trial labels for most of the major Pharmaceutical corporations. In the past 7 years ATL has produced more than 120 million pharmaceutical labels (including 19 page booklets), in over 80 languages, for over 1700 clinical trials. In business since 1951, ATL is an FDA Registered Medical Device manufacturer that also specializes in “private brand” disposable medical device manufacturing. See attached link Pharmaceutical Counterfeiting for more information: http://www.atlco.com/medical/PharmaAntiCounterfeiting.html
Counterfeit drugs pose significant public health and safety concerns. They may contain only inactive ingredients, incorrect ingredients, improper dosages, sub-potent or super-potent ingredients, or be contaminated. As a result, patients may be put at risk for serious adverse health consequences. For example, Procrit, a drug used by cancer and AIDS patients, was recently counterfeited and the drug was replaced with nonsterile tap water, which could have caused a severe infection of the bloodstream. In another recent counterfeiting incident, white tablets with “aspirin” imprinted on them replaced Zyprexa, a drug used for schizophrenia and acute bipolar disorder. This could have been particularly dangerous for patients who are aspirin-sensitive or aspirin-allergic or who have bleeding disorders. In addition, patients no longer received appropriate treatment for their illness. Counterfeiters also have been known to switch lower-strength drug(s) for higher strength drug(s). As a result, patients receive lower than expected doses of drug(s), leading to ineffective treatment and therapeutic failure.
Outside the United States, drug counterfeiting is known to be widespread and affects both developing and developed countries. For example, in South-East Asian countries, approximately 10% of drugs on the market are believed to be counterfeit. In China, authorities believe that for some drugs, counterfeits account for 50% of the product on the market. It is reported that in underdeveloped countries such as Argentina, Colombia, and Mexico, up to 40% of manufactured pharmaceuticals may be counterfeit.
As noted in the FDA’s Counterfeit Drug Task Force Interim Report http://www.fda.gov/oc/initiatives/counterfeit/report/ interim_report.html#IAe (Due to its length, this URL may need to be copied/pasted into your Internet browser’s address field. Remove the extra space if one exists.)
The IDGLOBAL Supply contract for anti-counterfeiting technology guarantees ATL the ability to incorporate IDGLOBALS’ Nano-Molecular Markers into any Pharmaceutical labeling solution. ATL and IDGLOBAL are already well positioned to address the massive counterfeiting concerns with unique, patented, Trademark proprietary solutions that no one else can provide. This will be extended to the mainstream OTC (over the counter) pharmaceutical product labeling opportunities with companies that are already solid, long-term ATL clients, as well as the emerging “nutraceutical” products manufacturers.
Donald Dobert, President and COO of ATL stated, “One of ATL’s primary goals is to help prevent counterfeiting and diversion of products and to help provide our client base a ‘workable’ pedigree solution. The addition of IDGLOBAL’s exceptional forensic marking technology adds significant value. No other pharmaceutical label manufacturer can deliver this level of brand integrity.”
Daryl Regier, President of IDGlobal stated, “We are extremely excited about our relationship with ATL as it provides IDGLOBAL unparalleled access to the pharmaceutical vertical through one strategic distribution point. It is IDGlobal’s strategy to align itself with companies and organizations that are leaders within their respective industries and our agreement with ATL is a perfect example of this strategy.”
About ATL (www.atlco.com)
One of ATL’s new innovations is the production of FDA compliant multi-panel booklet labels. In the past seven years, ATL has passed dozens of on-site audits performed by top pharmaceutical companies. ATL has established a well-respected name as the solutions provider in the tough arena of FDA cGMP Compliance. The company has implemented the strict regulations of 21 CFR 210, 211 and 820. Because of this track record, ATL is well known in the pharmaceutical community and is already an approved supplier (manufacturing high quality pharmaceutical labels). The transition to include anti-counterfeiting labels is a natural evolution of value-added products and services.
ATL also excels in “disposable medical device” manufacturing. As a 3M Preferred Medical Converter, ATL capabilities include island placement for transdermal patches, placebo patches, RFID “Smart Labels”, as well as laminating, custom die cutting, and printing. ATL specializes in “complete and customized private brand production” (engineering, manufacturing, pouching, sealing, packaging, and distribution) of “private brand” product.
New for 2007 (from ATL Pharma Security Label Systems(TM)) is their line of anti-counterfeiting “Secur-Book(TM)” labels. ATL multi-panel booklet labels are available with many tamper-resistant features, including “Pharma-Void(TM)”, “Secur-Detek(TM)”, and “Secur-Mark(TM)”.
About IDGLOBAL Corp. (www.idglobalcorp.com)
IDGLOBAL has two primary divisions, its Nano-Molecular Markers / Tags(TM) used in anti-counterfeiting applications and its IDFORENSIX(TM) products utilized in Loss Prevention for the $800 billion Anti-Counterfeiting and Loss Prevention markets.
IDGLOBAL’s Nano-Molecular Markers(TM) are the equivalent of taking the laboratory into the field and providing a verifiable answer as to a products authenticity in a matter of seconds by utilizing proprietary Nano-Molecular Markers(TM) and handheld scanning technologies. IDGLOBAL provides its Nano-Molecular Markers(TM) on a global basis and can easily be applied to product runs into the hundreds of millions of units at a cost of a fraction of a penny per unit. IDGLOBAL has established a multi-year track record of aiding in the protection of corporate assets and brand-name goods for major companies across North America. The Company is reviewing key alliance and acquisition opportunities to fast track growth and profitability.
The IDFORENSIX(TM) product lines are specifically geared towards loss prevention or corporate asset protection of assets such as tools, equipment up to and including fine art work. Much of corporate losses are due to internal and invasive theft. Applications for these forensic markers include everything from retail theft by consumers and/ or employees to the larger problem of theft in distribution systems and warehouses. The IDGLOBAL IDFORENSIX products mark, protect and identify merchandise and / or equipment to protect against theft. Literally, truck loads of product are stolen from companies that have very few options in proving and finding their stolen merchandise. Whether it’s boxes of music CDs or high gauge and expensive electrical wire literally removed from power grid systems, it all amounts to billions of dollars in theft and loss. IDFORENSIX products can also mark and protect everything from oil /gas and mining equipment where millions of dollars of field equipment and tools goes missing to forensically marking dozens, hundreds or even thousands of laptop computers in office environments. The IDFORENSIC markers cannot be removed or tampered with once applied and provide a long term and unequivocal ability for an organization to mark, protect and recover stolen articles and merchandise.
Nano-Molecular, Nano-Molecular Markers, Nano-Molecular Tags and IDFORENSIX are registered trademarks of IDGlobal Corp, All Rights Reserved.
This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of IDGLOBAL Corp. to be materially different from the statements made herein.
Contact:
IDGLOBAL Corp.
Daryl Regier, CEO, President
Philip Viggiani, VP, Sales Marketing
Marc Hamilton, Chief Operating Officer
Investor Relations Toll Free: 1-866-922-4345
Phone: 250-862-8933
Fax: 250-862-8322
www.idglobalcorp.com
View the StockGuru Profile for IDGLOBAL:
http://www.stockguru.com/profiles/idgj/
We Invite you to Visit the All New StockGuru Blog!
Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.
Click HERE to visit the Blog, or go to:
http://stockguru.com/blog/
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC expects to be compensated $15,000 directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
